These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 3004395)

  • 101. Expression of A and B tissue isoantigens in benign and malignant lesions of the breast.
    Strauchen JA; Bergman SM; Hanson TA
    Cancer; 1980 Apr; 45(8):2149-55. PubMed ID: 6245789
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Direct action of estrogen on sequence of progression of human preneoplastic breast disease.
    Shekhar MP; Nangia-Makker P; Wolman SR; Tait L; Heppner GH; Visscher DW
    Am J Pathol; 1998 May; 152(5):1129-32. PubMed ID: 9588879
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Ultrastructural localization of acridine orange binding to DNA of human breast cancer cells.
    Choksey AF; Sirsat SM; Jussawalla DJ
    Indian J Exp Biol; 1977 Aug; 15(8):601-5. PubMed ID: 203525
    [No Abstract]   [Full Text] [Related]  

  • 104. Identification of malignant cells in primary monolayer cultures of human breast tumors.
    Petersen OW; Briand P; van Deurs B
    Acta Pathol Microbiol Immunol Scand A; 1984 Mar; 92(2):103-12. PubMed ID: 6322514
    [TBL] [Abstract][Full Text] [Related]  

  • 105. A contribution to the natural history of breast cancer. III. Changes in the basement membranes in breast cancers with stromal microinvasion.
    Tulusan AH; Grünsteidel W; Ramming I; Egger H
    Arch Gynecol; 1982; 231(3):209-18. PubMed ID: 6289760
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Myoepithelial cells in lobular carcinoma in situ of the breast: a parallel immunocytochemical and ultrastructural study.
    Bussolati G; Botto Micca FB; Eusebi V; Betts CM
    Ultrastruct Pathol; 1981; 2(3):219-30. PubMed ID: 7197410
    [TBL] [Abstract][Full Text] [Related]  

  • 107. MCF10AT: a model for the evolution of cancer from proliferative breast disease.
    Dawson PJ; Wolman SR; Tait L; Heppner GH; Miller FR
    Am J Pathol; 1996 Jan; 148(1):313-9. PubMed ID: 8546221
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Atypia in breast fine-needle aspiration smears correlates poorly with the presence of a prognostically significant proliferative lesion of ductal epithelium.
    Stanley MW; Henry-Stanley MJ; Zera R
    Hum Pathol; 1993 Jun; 24(6):630-5. PubMed ID: 8505040
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study.
    Bartow SA; Pathak DR; Black WC; Key CR; Teaf SR
    Cancer; 1987 Dec; 60(11):2751-60. PubMed ID: 3677009
    [TBL] [Abstract][Full Text] [Related]  

  • 110. The ultrastructural heterogeneity of potentially preneoplastic lesions in the human bronchial mucosa.
    Gonzalez S; von Bassewitz DB; Grundmann E; Nakhosteen JA; Müller KM
    Pathol Res Pract; 1986 Aug; 181(4):408-17. PubMed ID: 3763480
    [TBL] [Abstract][Full Text] [Related]  

  • 111. The breast: tissue changes and cancer risk.
    Sinclair RA
    Med J Aust; 1988 Oct; 149(8):424-6. PubMed ID: 3173205
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Elastosis in benign and malignant breast disease.
    Parfrey NA; Doyle CT
    Hum Pathol; 1985 Jul; 16(7):674-6. PubMed ID: 2989149
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Independent submacroscopic foci of infiltrating carcinoma in breasts removed for clinical cancer.
    Sarnelli R; Squartini F
    Tumori; 1984 Apr; 70(2):169-78. PubMed ID: 6203200
    [TBL] [Abstract][Full Text] [Related]  

  • 114. [Lobular breast carcinoma in situ. Histogenesis, growth, transformation to an infiltrating carcinoma].
    Hamperl H
    Dtsch Med Wochenschr; 1971 Oct; 96(41):1585-8 passim. PubMed ID: 5098763
    [No Abstract]   [Full Text] [Related]  

  • 115. Male breast at autopsy.
    Andersen JA; Gram JB
    Acta Pathol Microbiol Immunol Scand A; 1982 May; 90(3):191-7. PubMed ID: 6285667
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Automated histometry in fibrocystic breast disease.
    Guski H; Hufnagl P; Freitag A; Wenzelides K; Voss K; Simon H
    Anal Quant Cytol Histol; 1988 Apr; 10(2):101-6. PubMed ID: 3390284
    [TBL] [Abstract][Full Text] [Related]  

  • 117. The prevalence of the precancerous lesions in breasts contralateral to clinical cancer. A morphological comparison with breasts containing a benign lump.
    Sarnelli R; Squartini F
    Clin Exp Obstet Gynecol; 1993; 20(1):37-42. PubMed ID: 8462186
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Is fibrocystic breast disease a pre-malignant state?
    Myhre E
    Acta Obstet Gynecol Scand Suppl; 1984; 123():189-91. PubMed ID: 6594011
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Collagen of breast with benign dysplasia.
    Jarocka-Cyrta E; Bańkowski E; Jodczyk KK
    Patol Pol; 1991; 42(3):83-6. PubMed ID: 1845483
    [TBL] [Abstract][Full Text] [Related]  

  • 120. The relationship of cyst type to risk factors for breast cancer and the subsequent development of breast cancer in patients with breast cystic disease.
    Dixon JM; Lumsden AB; Miller WR
    Eur J Cancer Clin Oncol; 1985 Sep; 21(9):1047-50. PubMed ID: 4065177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.